Rx Consulting to Rx banking lateral

I’m wondering how difficult this transition is. I have seen some people do it in the past, but how much of an uphill battle will it be to lateral from an rx consulting to rx banking role.

On the one hand, I feel like having rx experience will show that I am actually interested in rx, but on the other I understand there are some real technical differences between the consulting and banking sides of these deals.

A follow up question: which RX banks take laterals? It doesn’t seem like Moelis, PJT, Lazard, Evercore, HL have many at all. I have seen some more in T2/T3 rx groups.

Any insights would be appreciated, thank you in advance.

9 Comments
 
Most Helpful

I did it.

Back office -> big 4 consulting -> rx consulting small shop -> rx ib at a boutique -> m&a at a mm.

It was really hard. Lots of interviews through networking but would never convert. For the rx consulting to IB, I tried to connect the story to the similarities which was tough because I got questions around modeling (not bad actually), transaction details like how many iois you got (kind of tough to know bc your less plugged in, your MDs are prob more aware), how do you write a CIP and do u have an exp (no), do you work the same hours (no), etc. I saw one guy do it as a senior manager at a big 4 in rx and took an associate role at Raymond James. The whole rx PwC team went over b Riley to start their rx IB practice which is pure luck. The “associate” became an “associate” and “manager” became a vp. In consulting those titles don’t tie and neither does the comp.

I understand looking back why it was challenging, the skills are very different. The boutique IB that hired me was building a quasi consulting and rx practice. They wanted to be able to do both. So it was luck. We only did rx ib deals and it was a learning curve. It wasn’t difficult - but I was learning it all from scratch and didn’t appreciate that dynamic going in. Was very humbling and fortunately my md was very patient, partially bc he was a good guy but also bc he was building a new practice and loyalty > excellence in those first few months, and I was hire number 1. As we had more success his patience got a lot lower and other rx consulting candidates weren’t going to cut it for him anymore.

 

Explicabo sed quibusdam omnis fuga minus veritatis et molestiae. Qui rerum nobis sed sit inventore beatae. Eum impedit assumenda exercitationem odio autem exercitationem.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”